For catheterization labs performing both cardiac and vascular interventions, Philips Healthcare will highlight clinical tools like Allura 3D Coronary Angiography and StentBoost, as well as several new Allura Xper FD 20 features including a larger, tableside module with the ability to download images or runs to a USB stick.

October 8, 2008 – A new MRI-based method, delayed-enhancement cardiovascular MRI (DE-CMRI), allows doctors to detect and measure scarring on walls of heart after treated for atrial fibrillation (AF), according to a study published in the October 7, 2008, issue of the Journal of the American College of Cardiology.

October 7, 2008 – Philips contributes cardiovascular X-ray systems to hybrid surgery suites by STERIS Corp. to treat patients requiring minimally invasive cardiovascular surgical procedures, or those needing open surgery, within a single operating suite.

October 7, 2008 – CeloNova BioSciences Inc. will showcase the technology behind the CATANIA Coronary Stent System featuring a NanoThin Polyzene-F surface treatment at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium sponsored Oct. 12-17.

The CATANIA Coronary Stent System carries a CE Mark and is currently available for sale outside the U.S.

October 7, 2008 - ATS Medical Inc. last week launched U.S. sales of the ATS CryoMaze Surgical Ablation Clamp.

October 7, 2008 - Now in its 20th year the 2008 Transcatheter Cardiovascular Therapeutics (TCT) symposium, sponsored by the Cardiovascular Research Foundation, will take place from Sunday, Oct. 12 through Friday, Oct. 17 at the Washington Convention Center in Washington, D.C.

CeloNova BioSciences Inc.'s CATANIA Coronary Stent System features a NanoThin Polyzene-F surface treatment.

The CATANIA Coronary Stent System carries a CE Mark and is currently available for sale outside the U.S.

October 5, 2008 - New research shows warfarin therapy is significantly underused in patients being treated for atrial fibrillation (AF) in the U.S.

The new study is published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society. It concludes that not only is warfarin not prescribed as often as it could be, in many cases when warfarin is administered, it is not used at optimal therapeutic levels.

October 6, 2008 - Physio-Control Inc. last week announced FDA clearance to market the LIFEPAK 20e defibrillator/monitor in the U.S.

EmpowerCTA injector system offers both ACIST’s patented extravasation detection accessory (EDA) and a saline chase. This CT injector features air embolism protection, on-the-fly flow rate manipulation and syringe loading and arming at the injector.

EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the magnetic field of the MR scanner, including a hydraulic control system instead of the shielded electrical control components used by most other MR injector systems.

Subscribe Now